105 related articles for article (PubMed ID: 15084147)
41. [Expression of DLK1 gene in acute leukemias and its function in erythroid differentiation of K562 cell line].
Tang X; Long C; Wang C; Xiao G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 34(9):886-91. PubMed ID: 19779261
[TBL] [Abstract][Full Text] [Related]
42. Chemokine expression in human erythroid leukemia cell line AS-E2: macrophage inflammatory protein-3alpha/CCL20 is induced by inflammatory cytokines.
Inoue Y; Tsushima H; Ando K; Sawayama Y; Sakai M; Yamasaki R; Matsuo E; Tsutsumi C; Imaizumi Y; Iwanaga M; Imanishi D; Taguchi J; Miyazaki Y; Tomonaga M
Exp Hematol; 2006 Jan; 34(1):19-26. PubMed ID: 16413387
[TBL] [Abstract][Full Text] [Related]
43. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.
Drake SF; Morgan EH; Herbison CE; Delima R; Graham RM; Chua AC; Leedman PJ; Fleming RE; Bacon BR; Olynyk JK; Trinder D
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G323-8. PubMed ID: 16935854
[TBL] [Abstract][Full Text] [Related]
44. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation.
Lulli V; Romania P; Morsilli O; Gabbianelli M; Pagliuca A; Mazzeo S; Testa U; Peschle C; Marziali G
Cell Death Differ; 2006 Jul; 13(7):1064-74. PubMed ID: 16294212
[TBL] [Abstract][Full Text] [Related]
46. Hypoxia induces erythroid-specific 5-aminolevulinate synthase expression in human erythroid cells through transforming growth factor-beta signaling.
Kaneko K; Furuyama K; Aburatani H; Shibahara S
FEBS J; 2009 Mar; 276(5):1370-82. PubMed ID: 19187226
[TBL] [Abstract][Full Text] [Related]
47. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition.
Jacquel A; Colosetti P; Grosso S; Belhacene N; Puissant A; Marchetti S; Breittmayer JP; Auberger P
Oncogene; 2007 Apr; 26(17):2445-58. PubMed ID: 17043649
[TBL] [Abstract][Full Text] [Related]
48. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
[TBL] [Abstract][Full Text] [Related]
49. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo.
Kawabata H; Germain RS; Vuong PT; Nakamaki T; Said JW; Koeffler HP
J Biol Chem; 2000 Jun; 275(22):16618-25. PubMed ID: 10748106
[TBL] [Abstract][Full Text] [Related]
50. Identification of the membrane remnants of transferrin receptor with domain-specific antibodies.
Baynes RD; Shih YJ; Hudson BG; Cook JD
J Lab Clin Med; 1994 Mar; 123(3):407-14. PubMed ID: 8133153
[TBL] [Abstract][Full Text] [Related]
51. A specialized pathway for erythroid iron delivery through lysosomal trafficking of transferrin receptor 2.
Khalil S; Holy M; Grado S; Fleming R; Kurita R; Nakamura Y; Goldfarb A
Blood Adv; 2017 Jun; 1(15):1181-1194. PubMed ID: 29296759
[TBL] [Abstract][Full Text] [Related]
52. Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemia.
Kollia P; Samara M; Stamatopoulos K; Belessi C; Stavroyianni N; Tsompanakou A; Athanasiadou A; Vamvakopoulos N; Laoutaris N; Anagnostopoulos A; Fassas A
Leuk Res; 2003 Dec; 27(12):1101-3. PubMed ID: 12921947
[TBL] [Abstract][Full Text] [Related]
53. Myotonic dystrophy kinase-related CDC42-binding kinase α, a new transferrin receptor type 2-binding partner, is a regulator of erythropoiesis.
Richard C; Viret S; Cantero Aguilar L; Lefevre C; Leduc M; Faouzi EH; Azar N; Lavazec C; Mayeux P; Verdier F
Am J Hematol; 2021 Apr; 96(4):480-492. PubMed ID: 33476437
[TBL] [Abstract][Full Text] [Related]
54. Transferrin Receptors in Erythropoiesis.
Richard C; Verdier F
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352721
[TBL] [Abstract][Full Text] [Related]
55. Late expression of red cell membrane protein 4.2 in normal human erythroid maturation with seven isoforms of the protein 4.2 gene.
Wada H; Kanzaki A; Yawata A; Inoue T; Kaku M; Takezono M; Sugihara T; Yamada O; Yawata Y
Exp Hematol; 1999 Jan; 27(1):54-62. PubMed ID: 9923444
[TBL] [Abstract][Full Text] [Related]
56. Antigen of erythroblast (Ag-Eb): a membrane protein that may be an erythroid-specific transferrin receptor.
Fukson V; Kostyukov M; Toder V; Irlin JS; Firer MA
Med Hypotheses; 2000 Jan; 54(1):107-14. PubMed ID: 10791703
[TBL] [Abstract][Full Text] [Related]
57. Genetic screens reveal CCDC115 as a modulator of erythroid iron and heme trafficking.
Sobh A; Loguinov A; Zhou J; Jenkitkasemwong S; Zeidan R; El Ahmadie N; Tagmount A; Knutson M; Fraenkel PG; Vulpe CD
Am J Hematol; 2020 Sep; 95(9):1085-1098. PubMed ID: 32510613
[TBL] [Abstract][Full Text] [Related]
58. Transferrin receptor 2 is frequently and highly expressed in glioblastomas.
Calzolari A; Larocca LM; Deaglio S; Finisguerra V; Boe A; Raggi C; Ricci-Vitani L; Pierconti F; Malavasi F; De Maria R; Testa U; Pallini R
Transl Oncol; 2010 Apr; 3(2):123-34. PubMed ID: 20360937
[TBL] [Abstract][Full Text] [Related]
59. Current world literature.
Curr Opin Hematol; 2011 May; 18(3):197-201. PubMed ID: 21490471
[No Abstract] [Full Text] [Related]
60. Current world literature.
Curr Opin Hematol; 2010 May; 17(3):252-69. PubMed ID: 20393284
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
